Shandong Xinhua Pharmaceutical Company Limited Class H (0719) Financial Statements

2 Followers

Shandong Xinhua Pharmaceutical Company Limited Class H Financial Overview

Shandong Xinhua Pharmaceutical Company Limited Class H's market cap is currently HK$9.92B. The company's EPS TTM is HK$0.2864492325; its P/E ratio is 14.45; and it has a dividend yield of 4.47%. Shandong Xinhua Pharmaceutical Company Limited Class H is scheduled to report earnings on March 27, 2026, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	¥ 8.52B	¥ 8.47B	¥ 8.10B	¥ 7.50B	¥ 6.56B
Gross Profit	¥ 1.59B	¥ 2.04B	¥ 2.32B	¥ 2.04B	¥ 1.77B
Operating Income	¥ 337.37M	¥ 534.37M	¥ 534.58M	¥ 476.71M	¥ 425.59M
EBITDA	¥ 337.37M	¥ 1.11B	¥ 1.09B	¥ 1.01B	¥ 908.67M
Net Income	¥ 282.39M	¥ 470.02M	¥ 496.51M	¥ 411.06M	¥ 348.55M
Balance Sheet
Cash & Short-Term Investments	¥ 1.40B	¥ 1.25B	¥ 918.33M	¥ 1.16B	¥ 744.66M
Total Assets	¥ 9.19B	¥ 9.02B	¥ 8.29B	¥ 8.27B	¥ 7.33B
Total Debt	¥ 1.31B	¥ 1.35B	¥ 1.08B	¥ 1.38B	¥ 1.04B
Net Debt	¥ -84.19M	¥ 107.78M	¥ 166.60M	¥ 225.11M	¥ 299.09M
Total Liabilities	¥ 3.73B	¥ 3.80B	¥ 3.51B	¥ 3.92B	¥ 3.68B
Stockholders' Equity	¥ 5.21B	¥ 4.99B	¥ 4.55B	¥ 4.13B	¥ 3.47B
Cash Flow
Free Cash Flow	¥ 418.13M	¥ 155.19M	¥ -59.85M	¥ 513.48M	¥ 9.89M
Operating Cash Flow	¥ 533.73M	¥ 367.61M	¥ 265.28M	¥ 758.24M	¥ 259.12M
Investing Cash Flow	¥ -103.50M	¥ -212.21M	¥ -305.11M	¥ -228.90M	¥ -237.69M
Financing Cash Flow	¥ -291.13M	¥ 184.78M	¥ -196.11M	¥ -130.66M	¥ -139.73M

Currency in CNY

Shandong Xinhua Pharmaceutical Company Limited Class H Earnings and Revenue History

Income Statement >

Shandong Xinhua Pharmaceutical Company Limited Class H Debt to Assets

Balance Sheet >

Shandong Xinhua Pharmaceutical Company Limited Class H Cash Flow

Cash Flow >

Shandong Xinhua Pharmaceutical Company Limited Class H Forecast EPS vs Actual EPS

Earnings >